← Insider buys
RUBY

Rubius Therapeutics, Inc.

Chief Medical Officer Christopher L. Carpenter sold $647K of Rubius Therapeutics, Inc.

Sold$646,901
$13.48Price
48,000Shares
−58%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Mon, Dec 16. Filed Wed, Dec 18, 2:50 PM ET, during the session. Not investment advice.